학술논문

Rosiglitazone (PPAR gamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model
Document Type
Journal
Source
DIABETES OBESITY & METABOLISM; JAN 2003, 5 1, p45-p50, 6p.
Subject
Language
English
ISSN
14628902